William Hodder is the founder of NFlection Therapeutics. NFlection Therapeutics has raised $24M in total funding. Latest round: Series A. Based in Boston, MA.
William Hodder is the CEO of NFlection Therapeutics, a biotechnology company focused on developing targeted therapies for rare disorders, including neurofibromatosis type 1. Public filings and company communications also identify him as President in fundraising materials.
Full founder directory · Investor directory · Company funding database · Fundraising library